Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Anastasis Biotec
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Team== The core team: '''Prof. Agamemnon Epenetos, Chairman and Chief Executive Officer''' He is a successful biotechnology entrepreneur and qualified medical oncologist who has previously developed new drugs through to commercial production. '''Mr. Laurence Cohen, Part-time Company Secretary and Director''' Solicitor, formerly a Global Head of IP at Latham & Watkins, with expertise in legal, IPR, corporate governance and fund raising logistics. Consultant to a funding introducer for Phase 2 clinical trials. '''Dr. Mahendra Deonarain, Part-time Chief Operating Officer''' Oversees research and development, financial and logistical activities of the Company. He is involved in successful biotech start-ups and is a director of a commercial R&D laboratory. '''Prof. Raymond Moellering, Part-time Chief Scientific Officer''' Brings expertise on protein chemistry research and development. '''Matthew Cohen, Part-time''' Qualified Accountant with M&A and investor relations experience in a FTSE 100 company. The team is highly diverse and experienced, with a balance of scientific, medical and business skills. They have the requisite skills and expertise to successfully implement the Companyโs plans through to commercial fruition. Anastasis was set up from pioneering R&D at Imperial College. The team are motivated to produce an effective cancer treatment for the benefit of society as a whole. [[Category:Thesis]] [[Category:Equities]] __INDEX__
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)